M. Solomon (Toronto, Canada), H. Tiddens (Rotterdam, Netherlands)
Late Breaking Abstract: The activity of selected salivary proteases and glycosidases in whole saliva of cystic fibrosis patients
L. Minarowski, A. Minarowska, D. Sands, A. Karwowska, M. Knas, S. Szajda, E. Chyczewska (Bialystok, Warsaw, Poland)
|  |
Late Breaking Abstract: The effect of general anaesthesia in children with cystic fibrosis – A pilot study
C. Pandit, R. Valentin, J. DeLima, P. Robinson, D. Fitzgerald, P. Cooper, P. Van Asperen, D. Baines, H. Selvadurai (Sydney, Australia)
|  |
An anti-inflammatory effect of azithromycin in cystic fibrosis
S. S. Mok, M. Braithwaite, D. Clark, S. Sofianopoulos, S. Elmasry, F. Finlayson, E. Williams, D. Liew, S. Poole, M. Dooley, J. Wilson (Prahran, Fitzroy, Australia)
| |
An investigator driven, single-centre randomised, double blind comparative study of standard vs high dose intravenous meropenem, in adult cystic fibrosis patients
D. Clark, J. Armstrong, A. Young, R. Stirling, J. Wilson, D. Spelman, T. Kotsimbos (Melbourne, Australia)
| |
Voriconazole treatment in CF patients with ABPA and/or invasive aspergillosis
S. Van daele, P. Schelstraete, F. Haerynck, F. De Baets (Ghent, Belgium)
| |
Cystic fibrosis patients have different microbiological colonization comparing to other bronchiectasis
S. Rached, R. Athanazio, R. Carvalho-Pinto, F. Fernandes, A. Cukier, R. Stelmach (Brazil)
| |
Diagnostic value of serological tests against Pseudomonas aeruginosa in cystic fibrosis patients
A. Teper, L. Galanternik, A. Colom, F. Rapaport, A. Procopio (Caba, Argentina)
| |
Pneumococcal antibody levels in children with cystic fibrosis (CF)
P. Kenia, M. Browning, A. Claydon, C. O‘Callaghan, E. Gaillard (Leicester, United Kingdom)
| |
Incidence and resource utilisation of pulmonary exacerbations in patients with cystic fibrosis in the UK
J. Bradley, S. Blume, M. Balp, S. Elborn (Newtownabbey, United Kingdom; Wisconsin, United States Of America; Basel, Switzerland)
| |
Reliability & validity testing of the Seattle Pulmonary Exacerbation score in paediatric patients with CF
Y. Kernen, F. Keller, G. Hafen (Lausanne, Switzerland)
| |
Symptomatic sinus disease and use of antibiotics in cystic fibrosis
I. Shafiq, T. Daniels, M. Carroll, J. Nightingale (United Kingdom)
| |
Use of noninvasive mechanical ventilation in patients with cystic fibrosis
C. Llontop Guzmán, C. Prados Sánchez, L. Gomez Carrera, M. A. Gomez Mendieta, A. Santiago Recuerda, M. D. C. Martinez, R. Alvarez Sala, C. Antelo (Madrid, Spain)
| |
Imaging for insertion of indwelling venous access devices in patients with cystic fibrosis
K. Hester, A. Gascoigne, S. Bourke (Newcastle upon Tyne, United Kingdom)
| |
Prevalence of acute liver dysfunction and chronic liver disease in an Irish adult cystic fibrosis population
M. E. O‘Brien, T. Ho, O. O‘Connell, C. Shortt, D. Murphy, B. Plant (Cork, Ireland)
| |
Burkholderia cepacia infection in adult cystic fibrosis patients: Its impact on lung function and survival
E. Amelina, A. Cherniak, S. Krasovsky (Moscow, Russian Federation)
| |
Peculiarities of diabetes mellitus in cystic fibrosis adults
S. Chikina, V. Samoylenko, G. Babajanova, A. Nagorny, M. Khaziakhmetova (Moscow, Russian Federation)
| |